Exciting news in rheumatology! A recent study shows that non-invasive vagus nerve stimulation (nVNS) can significantly lower inflammatory markers in rheumatoid arthritis patients.
Recent research validates non-invasive vagus nerve stimulation (nVNS) as a potent bioelectronic tool for suppressing systemic inflammation. A double-blind, sham-controlled trial (n=52) targeted the auricular branch via transcutaneous stimulation of the tragus.
The protocol utilized two 5-minute sessions daily. Over 12 weeks, patients with rheumatoid arthritis showed a 42% reduction in TNF-α and a 37% decrease in IL-6. Clinical DAS28 scores improved by 1.8 points, significantly outperforming sham controls.
Mechanistically, nVNS activates the cholinergic anti-inflammatory pathway (CAP). Afferent signals to the nucleus tractus solitarius (NTS) trigger efferent fibers to release acetylcholine, which acts on splenic α7nAChR+ macrophages to suppress the NF-κB/NLRP3 inflammasome.
By increasing heart rate variability (HRV) by 25%, the biological equivalent of your body finally exhaling after a decade of holding its breath. This "neural dimmer switch" provides a precise, drug-free methodology for regulating neuroimmune firestorms.
Super exciting times for VNS !!!